Cargando…

Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma

Here we explore the role of the interplay between host immune response and epithelial-mesenchymal-transition (EMT)-Type tumor-budding on the outcome of pancreatic adenocarcinoma (PDAC). CD4+, CD8+, and FOXP3+T-cells as well as iNOS+ (M1) and CD163+-macrophages (M2) were assessed on multipunch tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wartenberg, Martin, Zlobec, Inti, Perren, Aurel, Koelzer, Viktor Hendrik, Gloor, Beat, Lugli, Alessandro, Eva, Karamitopoulou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414182/ https://www.ncbi.nlm.nih.gov/pubmed/25669968

Ejemplares similares

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013)

Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types
por: Zlobec, Inti, et al.
Publicado: (2013)

Tumor Budding in Upper Gastrointestinal Carcinomas
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015)

DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells
por: Ivanovska, Jelena, et al.
Publicado: (2015)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells
por: Ivanovska, Jelena, et al.
Publicado: (2017)

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
por: Galván, José A., et al.
Publicado: (2014)

Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer
por: Sokol, Lena, et al.
Publicado: (2015)

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study
por: Koelzer, Viktor H, et al.
Publicado: (2015)

Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012)

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
por: Zlobec, Inti, et al.
Publicado: (2014)

Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity
por: Sadozai, Hassan, et al.
Publicado: (2021)

Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study
por: Karamitopoulou, Eva, et al.
Publicado: (2020)

Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer
por: Zlobec, Inti, et al.
Publicado: (2021)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

Role of tumor size in the pre-operative management of rectal cancer patients
por: Zlobec, Inti, et al.
Publicado: (2010)

Tumour budding and its clinical implications in gastrointestinal cancers
por: Zlobec, Inti, et al.
Publicado: (2020)

Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2013)

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
por: Blank, Annika, et al.
Publicado: (2019)

Cytokeratin‐based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience
por: Koelzer, Viktor H, et al.
Publicado: (2017)

Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients
por: Zlobec, Inti, et al.
Publicado: (2012)

Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19
por: Koelzer, Viktor Hendrik, et al.
Publicado: (2022)

Differential pattern and prognostic significance of CD4(+), FOXP3(+ )and IL-17(+ )tumor infiltrating lymphocytes in ductal and lobular breast cancers
por: Droeser, Raoul, et al.
Publicado: (2012)

GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth
por: Li, Leanne, et al.
Publicado: (2018)

Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer
por: Georges, Laurent M. C., et al.
Publicado: (2019)

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
por: Koelzer, V H, et al.
Publicado: (2013)

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

The Tumor Microenvironment of Pancreatic Cancer
por: Karamitopoulou, Eva
Publicado: (2020)

The Tumor Border Configuration of Colorectal Cancer as a Histomorphological Prognostic Indicator
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer
por: Bokhorst, John-Melle, et al.
Publicado: (2023)

Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients
por: Helbling, Melina, et al.
Publicado: (2014)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
por: Zlobec, I, et al.
Publicado: (2014)

Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
por: Blank, Annika, et al.
Publicado: (2018)

The battle for prognosis at the invasive front of colorectal cancer
por: Lugli, Alessandro, et al.
Publicado: (2020)

Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer
por: Karamitopoulou, Eva
Publicado: (2013)

Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization
por: Skoworonska, Magdalena, et al.
Publicado: (2022)

CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
por: Koelzer, Viktor H, et al.
Publicado: (2014)

Clinical Scenarios Emerging from Combined Immunophenotypic, Molecular and Morphologic Analysis of Pancreatic Cancer: The Good, the Bad and the Ugly Scenario
por: Karamitopoulou, Eva, et al.
Publicado: (2019)

Immunophenotypic profile of tumor buds in breast cancer
por: Laedrach, C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c21h21rof61j2dbheg6p1f1gcb